Predict the regulatory effect of a non-coding variant
Hand Claude Code a single chr:pos:ref>alt variant and get back AlphaGenome’s predicted effect on expression, chromatin accessibility, histone marks, splicing, and transcription-factor binding — with tissue-resolved tracks and an in-silico mutagenesis logo for the disrupted motif.
| Problem class | Knowledge synthesis |
| Subject areas | Molecular and Cellular Biology, Integrative Structural and Computational Biology |
| Evidence level | Reported |
| Complexity | One skill or MCP |
| Availability | Subscription required |
| Compute | Laptop |
Problem
A GWAS hit or a rare-disease exome lands on a variant that is nowhere near a coding region. ClinVar is silent, the variant is in an intron or an intergenic enhancer, and the question is mechanistic: does this base change touch a regulatory element, and if so, which gene, which tissue, and which molecular readout (expression up/down, a lost TF footprint, a cryptic splice site)? Wet-lab follow-up — a reporter assay, an eQTL look-up — is slow and not always available for the right cell type. A sequence-to-function model can generate the testable hypothesis in seconds. Solved looks like: a ranked summary of the variant’s predicted molecular consequences across relevant tissues, the affected gene, and a sequence logo showing what regulatory motif the alt allele breaks or creates.
Recommended approach
-
Get an AlphaGenome API key. Sign up at deepmind.google.com/science/alphagenome, accept the non-commercial research terms, and copy the key. Install
uvif you don’t have it:curl -LsSf https://astral.sh/uv/install.sh | sh echo "ALPHAGENOME_API_KEY=<your-key>" >> ~/.env -
Install the AlphaGenome single-variant skill from DeepMind’s science-skills collection (manual copy is the Claude path):
git clone https://github.com/google-deepmind/science-skills cp -r science-skills/skills/alphagenome_single_variant_analysis ~/.claude/skills/ cp -r science-skills/skills/scienceskillscommon ~/.claude/skills/ -
Resolve the tissue context first. The model is tissue-resolved, so name the cell type that matters for your phenotype. Have Claude run the skill’s
resolve_ontology_terms.pyto map “pancreatic beta cell” or “CD4 T cell” to its UBERON/CL ID before scoring. -
Score the variant. A minimal prompt:
Run the alphagenome_single_variant_analysis skill on chr11:5226774:T>A (GRCh38). Score RNA-seq expression, DNASE accessibility, ChIP histone marks, and TF binding in the relevant blood/erythroid cell types. Identify the affected gene, rank the modalities by effect size, run analyze_ism.py for the disrupted motif, and run interpret_splicing.py if any splice signal changes. -
Read the ranked output and the ISM logo. The skill emits reference-vs-alternate tracks per modality, a splicing-disruption analysis, and an in-silico mutagenesis sequence logo. Treat the top-ranked modality as the lead hypothesis (e.g., “abolishes a GATA1 footprint → reduces enhancer accessibility → lowers target expression in erythroid cells”) and confirm the gene assignment with the skill’s offline GTF lookup before reporting.
Why this assembly
Rung 2 of the simplicity ladder. The hard part — a 1 Mb sequence-to-function model spanning every regulatory modality — is the AlphaGenome API; the skill is the thin orchestration layer that resolves ontologies, calls the API, and renders tracks and ISM logos. Plain Claude Code (rung 1) cannot predict molecular phenotypes from sequence; it has no model. There is nothing to escalate to at rung 3/4 — this is a single-model query, and the model is state of the art for the task. The one judgment call the recipe adds is naming the right tissue, because cell-type-specific regulation is exactly where the model is weakest.
Availability
Subscription required (free-tier, but gated). The AlphaGenome API is a signup-gated research preview, free for non-commercial use with an API key and acceptance of the terms — commercial use is not covered. The skill code itself is OSS (Apache-2.0 code, CC-BY-4.0 docs). Note: the skill’s primary npx skills add install path targets Gemini/Antigravity; for Claude use the manual copy shown above.
Compute requirements
Laptop-sufficient on the client side — all heavy computation runs server-side on the AlphaGenome API. A single-variant scoring call returns in roughly a second to a few seconds of model time; the skill installs its own Python deps via uv on first run. No local GPU. Network access to the API is required.
Evidence
Reported. AlphaGenome is peer-reviewed: Advancing regulatory variant effect prediction with AlphaGenome, Nature 2026 reports that the model matches or exceeds the strongest available external models on 25 of 26 variant-effect-prediction evaluations, and on 22 of 24 single-sequence prediction tasks — while being the only model that jointly predicts all assessed modalities. The paper recapitulates the mechanisms of clinically relevant variants near the TAL1 oncogene as a worked case. Experts note a caveat the recipe inherits: cell-type-specific regulation remains the model’s weakest dimension, so tissue choice matters.
No peer-reviewed benchmark of “Claude + the AlphaGenome skill” specifically is known; the agent loop wraps the published API and adds ontology resolution and visualization, not a new model. The quantitative anchor is the Nature paper.
Alternatives considered
- Interpret a clinical variant. Reach for that recipe when the variant is coding or already in ClinVar/gnomAD — it does database-anchored clinical interpretation. This AlphaGenome recipe is for the non-coding, regulatory, mechanism-unknown case where the databases are silent.
- eQTL/regulatory database lookup (GTEx). If your variant is a known eQTL in the tissue you care about, a GTEx lookup is cheaper and observational rather than predicted. AlphaGenome wins when no eQTL exists for your variant or your cell type.
- Plain Claude Code. Cannot predict sequence-to-function effects; it would only summarize what databases already say. Not an option for novel non-coding variants.
See also
- AlphaGenome Single-Variant Analysis (Claude Skill)
- Interpret a clinical variant
- Score protein variants with ESM
- GTEx (database)
Sources
- Advancing regulatory variant effect prediction with AlphaGenome, Nature 2026 — published 2026-01-28; verified 2026-06-20 (this run).
- AlphaGenome preprint, bioRxiv 2025 — published 2025-06-25; verified 2026-06-20 (this run).
google-deepmind/science-skills(alphagenome_single_variant_analysis) — verified 2026-06-20 (this run).
Tried this recipe?
Share feedback — what worked, what didn’t, what you’d change. The form opens with this recipe pre-selected and a link back to this page.